Arcadia Biosciences, Inc.
RKDA
$3.46
$0.20196.21%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -35.49% | -18.89% | -4.62% | -26.98% | -25.85% |
| Total Receivables | 13.29% | 4.23% | 241.97% | 50.20% | 66.45% |
| Inventory | 8.26% | -14.62% | -46.59% | 118.76% | -68.50% |
| Prepaid Expenses | 78.69% | -2.98% | 0.37% | -33.71% | -26.17% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 37.14% | -66.98% | 1,313.33% | -98.73% | 368.25% |
| Total Current Assets | -13.71% | -13.86% | 6.80% | -22.24% | -25.16% |
|
|
|||||
| Total Current Assets | -13.71% | -13.86% | 6.80% | -22.24% | -25.16% |
| Net Property, Plant & Equipment | -50.69% | -36.33% | -44.57% | 18.68% | -46.63% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 0.00% | 0.00% | 0.00% | 0.00% | -2.50% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -1.74% | -4.60% | 29.53% | -12.79% | 112.30% |
| Total Assets | -11.31% | -12.25% | 8.25% | -18.57% | -16.03% |
|
|
|||||
| Total Accounts Payable | -58.45% | 8.46% | -9.93% | 257.11% | -81.36% |
| Total Accrued Expenses | 3,973.33% | -62.50% | 6.67% | -94.64% | 2,941.30% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -55.20% | -38.54% | -29.71% | -5.99% | -7.79% |
| Total Finance Division Other Current Liabilities | 85.77% | -47.47% | 83.33% | -68.38% | 172.84% |
| Total Other Current Liabilities | 85.77% | -47.47% | 83.33% | -68.38% | 172.84% |
| Total Current Liabilities | 10.09% | -13.71% | -6.25% | -19.83% | -7.59% |
|
|
|||||
| Total Current Liabilities | 10.09% | -13.71% | -6.25% | -19.83% | -7.59% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -47.62% | -86.45% | -55.33% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 71.16% | -10.67% | 16.14% | -18.21% | -15.09% |
| Total Liabilities | 43.24% | -12.25% | 4.31% | -20.55% | -13.21% |
|
|
|||||
| Common Stock & APIC | 0.04% | 0.06% | 0.04% | 0.05% | 0.05% |
| Retained Earnings | -1.48% | -0.59% | 0.39% | -0.89% | -1.06% |
| Treasury Stock & Other | -- | 44.44% | -49.69% | 59.41% | 16.09% |
| Total Common Equity | -39.51% | -12.11% | 10.20% | -17.29% | -17.35% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -39.51% | -12.11% | 10.20% | -17.29% | -17.35% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Equity | -38.68% | -12.25% | 10.33% | -17.48% | -17.50% |
|
|
|||||